BioLight announced today that following its announcement on November 25, 2015 of BioLight’s IOPtima Ltd. subsidiary regarding entering into a joint financing agreement with two Asia-based venture capital firms, according to which the New Investors will invest an aggregate amount of US$6.0 million in consideration for the issuance of approximately 29% of IOPtima’s issued and outstanding shares (post investment), on December 28, 2015, all closing terms were completed and IOPtima received the Investment Amount against said share issuance.
Link to Newsroom